久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • FDA Expands Indication for PROGRAF? for Lung Transplant Recipients americanpharmaceuticalreview
    July 22, 2021
    Astellas Pharma Inc. announced that the U.S. FDA approved its supplemental New Drug Application (sNDA) for PROGRAF? (tacrolimus) for the prevention of organ rejection in adult and pediatric lung transplant recipients.
  • Elevated Risk for Lung CA in Lung Transplant Recipients Explored drugs
    December 28, 2018
    Recipients of a lung transplant, especially a single lung transplant, have an elevated risk for lung cancer, particularly in the native lung, according to a study published online Dec. 18 in the?American Journal of Transplantation......
PharmaSources Customer Service